MetLife Investment Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,059
| Closed | -$237K | – | 2845 |
|
|
2023
Q4 | $237K | Buy |
15,059
+2,361
| +19% | +$37.2K | ﹤0.01% | 2142 |
|
|
2023
Q3 | $98.4K | Hold |
12,698
| – | – | ﹤0.01% | 2586 |
|
|
2023
Q2 | $126K | Hold |
12,698
| – | – | ﹤0.01% | 2545 |
|
|
2023
Q1 | $73.6K | Hold |
12,698
| – | – | ﹤0.01% | 2662 |
|
|
2022
Q4 | $101K | Buy |
+12,698
| New | +$101K | ﹤0.01% | 2590 |
|
|
2022
Q2 | – | Sell |
-15,326
| Closed | -$108K | – | 2925 |
|
|
2022
Q1 | $108K | Buy |
15,326
+10,069
| +192% | +$70.9K | ﹤0.01% | 2611 |
|
|
2021
Q4 | $120K | Hold |
5,257
| – | – | ﹤0.01% | 2338 |
|
|
2021
Q3 | $156K | Buy |
+5,257
| New | +$156K | ﹤0.01% | 2239 |
|